IDEXX LABORATORIES INC /DE Goodwill, Acquired During Period
IDEXX LABORATORIES INC /DE (IDXX) reported Goodwill, Acquired During Period of $45.78 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-21.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2025-02-21
- IDEXX LABORATORIES INC /DE goodwill, acquired during period for the quarter ending 2015-12-31 was $47.00K.
- IDEXX LABORATORIES INC /DE goodwill, acquired during period for the quarter ending 2013-12-31 was $541.00K.
- IDEXX LABORATORIES INC /DE goodwill, acquired during period for fiscal 2024 was $45.78M.
- IDEXX LABORATORIES INC /DE goodwill, acquired during period for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE goodwill, acquired during period for fiscal 2022 was $8.50M, a 92.94% decline from fiscal 2021.
- IDEXX LABORATORIES INC /DE goodwill, acquired during period for fiscal 2021 was $120.35M, a 54602.73% increase from fiscal 2020.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|
| 2024-12-31 | $45.78M 10-K · filed 2025-02-21 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-02-21 | ||
| 2022-12-31 | $8.50M 10-K · filed 2025-02-21 | ||
| 2021-12-31 | $120.35M 10-K · filed 2024-02-22 | ||
| 2020-12-31 | $220.00K 10-K · filed 2023-02-16 | ||
| 2019-12-31 | $24.83M 10-K · filed 2022-02-16 | ||
| 2018-12-31 | $20.28M 10-K · filed 2021-02-12 | ||
| 2017-12-31 | $13.54M 10-K · filed 2020-02-14 | ||
| 2016-12-31 | $1.72M 10-K · filed 2019-02-15 | ||
| 2015-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $5.05M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $5.00M 10-Q · filed 2015-10-28 | ||
| 2014-12-31 | $13.08M 10-K · filed 2017-02-17 | ||
| 2013-12-31 | $541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $6.74M 10-K · filed 2016-02-17 | |
| 2013-09-30 | $6.20M 10-Q · filed 2013-10-22 | ||
| 2011-12-31 | $24.69M 10-K · filed 2014-02-18 | ||
| 2009-12-31 | $2.33M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |